Alnylam Pharmaceuticals
ALNY
$315.75
Share price
0.26%
Change (1 day)
23.25%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Operating Margin for Alnylam Pharmaceuticals (ALNY)
Operating Margin as of July 2025 (TTM): -16.78%
According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -16.78%. At the end of 2024 the company had an Operating Margin of -16.79%.
Operating Margin history for Alnylam Pharmaceuticals from 2003 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -16.79% | -29.21% |
| 2023 | -23.71% | -78.17% |
| 2022 | -108.63% | 7.63% |
| 2021 | -100.93% | -41.86% |
| 2020 | -173.60% | -56.91% |
| 2019 | -402.85% | -60.33% |
| 2018 | -1,015.48% | 86% |
| 2017 | -545.95% | -37.22% |
| 2016 | -869.63% | 23.21% |
| 2015 | -705.83% | -10.92% |
| 2014 | -792.32% | 306.56% |
| 2013 | -194.88% | 11.54% |
| 2012 | -174.73% | 150.82% |
| 2011 | -69.66% | 62.06% |
| 2010 | -42.98% | -8.07% |
| 2009 | -46.76% | 76.12% |
| 2008 | -26.55% | -83.16% |
| 2007 | -157.61% | 7.45% |
| 2006 | -146.68% | -80.71% |
| 2005 | -760.53% | 0.84% |
| 2004 | -754.18% | -93.51% |
| 2003 | -11,618.18% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Arrowhead Pharmaceuticals
ARWR | -17,247.50% | 102,686.05% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 35.38% | -310.85% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -7.35% | -56.20% | 🇺🇸 USA |
 OPKO Health
OPK | -0.08% | -99.52% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | -118.00% | 603.22% | 🇺🇸 USA |
 Novartis NVS | 28.02% | -266.98% | 🇨🇭 Switzerland |
 Sanofi SNY | 15.12% | -190.11% | 🇫🇷 France |
 Teva Pharmaceutical Industries TEVA | -7.76% | -53.75% | 🇮🇱 Israel |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.